FDA issues most serious recall for two Smiths Medical infusion pumps

The Food and Drug Administration issued Class I recalls, the most serious type, for two Smiths Medical infusion pumps due to the potential for serious injury or death. Certain CADD-Solis Ambulatory Infusion Pumps and CADD-Solis VIP Ambulatory Infusion Pumps have updated use instructions following issues with a false occlusion alarm, a thermal damage issue and an intermittent connection issue. The issues could result in interruptions or therapy delays, depending on the clinical situation and type of medication being administered. Smiths Medical has not reported any serious injuries or deaths associated with the issues.